Navigation Links
Variable gene expression in zebrafish
Date:4/28/2014

This news release is available in German.

Early embryonic development of vertebrates is controlled by the genes and their "grammar". Decoding this grammar might help understand the formation of abnormalities or cancer or develop new medical drugs. For the first time, it is now found by a study that various mechanisms of transcribing DNA into RNA exist during gene expression in the different development phases of zebrafish. This study is presented by KIT researchers in the journal "Nature".

After several genomes have been sequenced and human genetic material has been decoded, many questions regarding the structure and function of genetic information still remain unanswered. On the DNA (deoxyribonucleic acid), the carrier of genetic information, scientists search for the grammar regulating gene expression, for instance. The result of this gene expression is the RNA (ribonucleic acid) that converts genetic information into proteins. A major pro-cess of gene expression is transcription, by which RNA is synthe-sized according to a DNA template. However, it is still unknown where exactly transcription starts and which regularly recurring DNA segments, DNA modifications or structural modifications of the DNA are required to determine the start of transcription. Complete understanding of transcription regulation might allow for specific interference with these mechanisms and the development of new medical drugs against diseases.

An international team of scientists, including Uwe Strhle, Head of the Institute of Toxicology and Genetics (ITG) of KIT, and his staff members Dr. Olivier Amant and Dr. Marco Ferg, studied the pro-cesses associated with the start of transcription in zebrafish in more detail. The ITG runs the European Zebrafish Resource Center (EZRC), a central archive for fish cultivation and dissemination and screening center. In genetics, the zebrafish is considered an im-portant model organism for studies of vertebrates. Using the CAGE (Cap Analysis of Gene Expression) high-throughput method, the scientists determined the starting points of transcription of many thousands of genes in various phases of embryonic development of zebrafish.

Comparison of the data revealed that use of certain starting points differs in two phases of embryonic development in particular: Before and after activation of the embryonic genome. "Prior to activation, the growing embryo uses transcripts deposited by the mother in the egg for the production of proteins," explains Dr. Marco Ferg, ITG. "The genome of the mother acts as a matrix or complementary template. After activation of the embryonic genome, the transcripts are newly produced. Then, the genome of the embryo serves as a matrix." With the help of so-called next-generation sequencing methods for decoding unknown DNA sequences at high throughputs, the ITG researchers were the first to find out that various transcription mechanisms exist in various development phases.

Further studies are needed to determine whether the specific use of transcription starting points is a widely disseminated mechanism for gene regulation. "If this is the case, it might be possible to control transcription and to specifically counteract diseases like cancer, which are caused by defective transcription," Marco Ferg says. "However, we are still in the phase of fundamental research."


'/>"/>

Contact: Monika Landgraf
presse@kit.edu
49-721-608-47414
Karlsruher Institut fr Technologie (KIT)
Source:Eurekalert  

Related medicine news :

1. Price for hip replacement highly variable, hard to obtain
2. PCa markers improve predictive performance of existing clinical variables
3. Chicago Digital Printer Introduces Variable-Data Printing for Bulk iPhone Case Orders
4. Variable Valve Timing & Start-Stop Systems Market is Estimated to Grow at Highest CAGR of 16.43% from 2013 to 2018 – New Report by MarketsandMarkets
5. Variable Valve Timing Market and Start-Stop Systems is poised to grow up to 88.8 Million units and $9.8 Billion by 2018 - New Report by MarketsandMarkets
6. Changes in gene expression may help explain high blood pressure in pregnancy
7. Control of gene expression: Histone occupancy in your genome
8. Overexpression of proteins 14-3-3 related to chemotherapy resistance
9. Gene expression test identifies low-risk thyroid nodules
10. Gene expression improves the definition of a breast cancer subtype
11. Synthetic circuit allows dialing gene expression up or down in human cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Variable gene expression in zebrafish
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of ... its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his ... July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... ... 12, 2017 , ... The American College of Medical Informatics (ACMI) will present ... the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... Collen, a pioneer in the field of medical informatics, this prestigious award is presented ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Denmark , Oct. 2, 2017 The Rebound ... in the struggle to reverse the tide of prescription drug ... for regulating their medicine intake and stepping down their dosage ... set to launch in December 2017; the first 100,000 people ... Learn more at http://www.rebound-solution.com/ ...
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
Breaking Medicine Technology: